Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Public ClinicalTrials.gov record NCT05257551. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Tempus SCLC Observational Study: A Tissue and Longitudinal Circulating Tumor DNA (ctDNA) Biomarker Profiling Study of Patients With Small Cell Lung Cancer (SCLC) Using Comprehensive Next-Generation Sequencing (NGS) Assays
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is a non-interventional evaluation of participants with extensive stage (ES) SCLC who will receive diagnostic and (where possible) post-progression tumor tissue profiling, alongside plasma ctDNA and CTC biomarker profiling during standard of care therapy in both first and second line treatment.
Study identification
- NCT ID
- NCT05257551
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 12, 2022
- Primary completion
- Feb 28, 2029
- Completion
- Feb 28, 2029
- Last update posted
- Jun 14, 2026
2022 – 2029
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cancer and Blood Specialty Clinic | Los Alamitos | California | 90720 | Withdrawn |
| University of Colorado | Aurora | Colorado | 80045 | Recruiting |
| Illinois Cancer Care | Peoria | Illinois | 61615 | Recruiting |
| Johns Hopkins University | Baltimore | Maryland | 21287 | Recruiting |
| Englewood Health Medical Center | Englewood | New Jersey | 07631 | Withdrawn |
| University of North Carolina | Chapel Hill | North Carolina | 27599 | Recruiting |
| TriHealth Cancer Institute | Cincinnati | Ohio | 45220 | Recruiting |
| Ohio State University | Columbus | Ohio | 43210 | Recruiting |
| OhioHealth Research Institute | Columbus | Ohio | 43214 | Withdrawn |
| Oklahoma Cancer Specialists and Research Institutes | Tulsa | Oklahoma | 74146 | Withdrawn |
| Cancer Care Association of York | York | Pennsylvania | 17403 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05257551, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 14, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05257551 live on ClinicalTrials.gov.